Beijing Hotgen Biotech Co., Ltd.
Beijing Hotgen Biotech Co., Ltd.
  • liver disease test
  • liver disease test

Liver Disease Test (UPT) Kits

The latest global cancer burden data (Globocan 2020) shows that primary liver cancer is the sixth most common malignancy.Globally, an estimated 905,700 people are diagnosed with liver cancer and 830,200 die from it.More than half of the world's estimated liver cancer cases and deaths occur in East Asia (54.3% and 54.1%, respectively).

Liver diseases are progressive disease, so early diagnose and timely treatment is important way to stop it.

Products
Want to Get More Details about lVD Products?

Discover the precision and reliability of Hotgen IVD products. Contact us today to enrich your product portfolio & enhance your diagnostic capabilities and patient care.